Pixels & Pills

Entries Tagged as 'public relations'

New Graduates: Why Pharma Is the Place to Be

June 15th, 2011 · No Comments · Knowledge, Trends

By Scott Neverett (@scottneverett)
It’s a good time to pursue a career in health care.
According to the most recent data by the U.S. Bureau of Labor Statistics, health care added another 37,000 jobs in April. For new graduates turning the tassel from right to left, why not consider a career in a thriving industry that offers [...]

Share

[Read more →]

Tags:···················

Defining Moments of 2010: April

April 20th, 2011 · 1 Comment · News, Opinion

The Defining Moments series looks back at the biggest events of 2010 to see what we can learn from them here at P&P, to work better in our calling, in 2011 and beyond.
By DJ Edgerton (@wiltonbound)
The first quarter of 2010 gave us startling, literally earth-shaking, events in Haiti and Iceland, and the shocking [...]

Share

[Read more →]

Tags:················

Defining Moments of 2010: February

February 18th, 2011 · No Comments · News, Opinion

The Defining Moments series looks back at the biggest events of 2010 to see what we can learn from them here at P&P, to work better in our calling, in 2011 and beyond.
By DJ Edgerton (@wiltonbound)
January saw the nation of Haiti – and the world, in sympathy – reeling from a devastating earthquake.
In [...]

Share

[Read more →]

Tags:··············

Choosing a Spokesperson

September 15th, 2010 · No Comments · Opinion

Image courtesy of Discovery Health
By Jessica Goldsmith
Who is the voice of your organization?
For most organizations, the company voice is reflected in marketing materials, public relations efforts, on social networks and through brand ambassadors such as corporate or celebrity spokespeople. But in health care, spokespeople are often patients themselves. As pharma companies look to inform, educate [...]

Share

[Read more →]

Tags:············

Has Social Media Made “Crisis Communications” a Thing of the Past?

August 9th, 2010 · No Comments · Opinion

By Sven Larsen (@zemoga)
On July 26 at the ExL Pharma 6th Annual Public Relations & Communications Summit, Deborah Sittig led a panel discussion called “Social Media in a Crisis” (for a full report on the session, including a summary from Sittig herself, check out John Mack’s post, “Using Social Media in a Crisis”).
A lot of [...]

Share

[Read more →]

Tags:··········

Watching the Media: Avandia

July 27th, 2010 · No Comments · News, Opinion

Image courtesy of Present Diabetes
By Russ Ward (@russcward)
Over the last couple of weeks, if you haven’t heard people talking about Avandia, GlaxoSmithKline’s diabetes drug, you must have been on that mythical desert island that people always talk about.
The FDA convened a hearing to discuss the drug – and specifically, to discuss the heart attacks that [...]

Share

[Read more →]

Tags:················

The Six A’s for Managing Legal Disputes

June 11th, 2010 · 8 Comments · Knowledge, Opinion

Kristie Kuhl, JD, Senior Vice President, Makovsky + Co is a counselor on issues that impact biotechnology, specialty pharma, health-product distribution and medical devices.   She led issues management teams assisting US-based B. Braun in response to hospital-related crises. Kristie also led the Agency team that launched Alexion’s Soliris, [...]

Share

[Read more →]

Tags:·········

How Do You Market Pharma Where DTC is Illegal?

June 2nd, 2010 · 5 Comments · Opinion

This post will continue our week-long theme of “Pharma Without Borders,” which inspects how Pharma companies engage with doctors and patients overseas.
By Russ Ward (@russcward)
Sometimes we forget that DTC is unusual and new in the global pharmaceutical market. But direct-to-consumer (DTC) advertising of prescription drugs is illegal everywhere in the world with two exceptions. The [...]

Share

[Read more →]

Tags:···········